Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Launch76336 grounded factsnewest September 2, 2026, 7:58 AM ETRSS · JSON
Showing 5851–5900 of 76336
Departed
Ho Seok (Roberto) Kim
Chief Financial Officer
CORETEC GROUP INC.
Effective
2024-11-18
Successor
Antti Uusiheimala
Filed
November 20, 2024, 6:59 PM ET
Ho Seok (Roberto) Kim resigned as Chief Financial Officer of the Company, which resignation was not as a result of any disagreements with the Company or its management.
Departed
Kimberly Johnson
Senior Vice President, Controller and Principal Accounting Officer
Kimberly Johnson, the Company's current Senior Vice President, Controller and Principal Accounting Officer, announced her plans to retire from the Company effective January 3, 2025.
Departed
Alfredo Papadakis
sole Director and officer
VGTel, Inc.
Effective
2024-10-22
Successor
Ken Williams
Filed
November 20, 2024, 6:59 PM ET
Our Company’s current sole Director and officer Alfredo Papadakis has resigned, and Ken Williams has been appointed as sole director and President, Secretary and CFO.
Brian J. Lipke informed the Board of Directors (the “Board”) of Moog Inc. (the “Company”) that he intends to retire from the Board immediately prior to the Company’s 2025 annual meeting of shareholders
On November 13, 2024, Stacy Loretz-Congdon communicated to the Board of Directors (the “Board”) of Farmer Bros. Co., a Delaware corporation (the “Company”), her decision not to stand for reelection as a member of the Board at the Company’s 2025 Annual Meeting of Stockholders.
Departed
Rajneesh Vig
Director
BlackRock Direct Lending Corp.
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, Mr. Vig informed the Company that his resignation as Director of the Company will be effective as of the close of business on November 15, 2024.
Departed
Rajneesh Vig
Trustee
BlackRock Private Credit Fund
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, Mr. Vig informed the Company that his resignation as a Trustee of the Company will be effective as of the close of business on November 15, 2024.
Departed
David I. Chemerow
director
RiceBran Technologies
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
Departed
Brent D. Rosenthal
director
RiceBran Technologies
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
Departed
Georgina Russell
director
RiceBran Technologies
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
Departed
Andrew Call
Director
ALPINE 4 HOLDINGS, INC.
Effective
2024-11-14
Filed
November 19, 2024, 6:59 PM ET
On November 14, 2024, Andrew Call submitted his resignation as a member of the Board of Directors (the “Board”), as well as from his position as Chair of the Audit Committee of the Board, effective immediately.
Accordingly, on that date, Mr. Wright resigned from his positions as Chairman of the Board, Director and Chief Executive Officer of the Company, effective upon and subject to the Confirmation Condition.
Accordingly, on that date, Mr. Wright resigned from his positions as Chairman of the Board, Director and Chief Executive Officer of the Company, effective upon and subject to the Confirmation Condition.
Jamie Siminoff, the Company’s Chief Strategy Officer, mutually agreed that Mr. Siminoff would step down as the Company’s Chief Strategy Officer on December 31, 2024 (the “Siminoff Separation Date”).
On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation (the “ Company ”) terminated the employment of Tao Levy, the Company’s Executive Vice President, Business Development.
Departed
John C. Lee, Jr.
President and Chief Executive Officer
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2025-02-01
Successor
Christopher F. Cosby
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, John C. Lee, Jr. gave notice of his resignation as President and Chief Executive Officer ("CEO") of Old Dominion Electric Cooperative ("ODEC"), effective February 1, 2025.
On November 14, 2024, Ann Taylor notified Terns Pharmaceuticals, Inc. (the “Company”) of her resignation from the Company’s Board of Directors (the “Board”), effective as of November 18, 2024.
On November 12, 2024, Steve Richards, the Company’s Chief Executive Officer (“CEO”), announced his retirement as Chief Executive Officer of the Company, effective December 2, 2024.
On November 15, 2024, Gregory M. Share informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as a director of the Company.
On November 15, 2024, Genesis Energy L.P. (the “Company”) announced that Robert V. Deere, the Company’s Chief Administrative Officer, intends to retire from his position at the Company effective December 31, 2024.
Departed
Timothy Tyson
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed
David Roth
Chief Medical Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed
S. Gail Eckhardt
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed
Conley Chee
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Filed
November 18, 2024, 6:59 PM ET
In addition, Mr. Chee resigned from the Board of Directors and all committees or subcommittees thereof, effective upon his termination of employment on November 22, 2024.
Departed
Deborah Dunsire
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed
Conley Chee
President and Chief Executive Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Successor
Gerald Quirk
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed
Srinivas Akkaraju
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed
Andrew M. Oh
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-12
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, Andrew M. Oh notified the Board of Directors of the Company of his resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed
Jason Haas
Chief Financial Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Successor
Gerald Quirk
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed
Richard Young
Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Departed
Steven P. Rasche
Executive Vice President and Chief Financial Officer
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Departed
Anthony S. Chan
Chief Financial Officer
SHARING SERVICES GLOBAL Corp
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, Anthony S. Chan ceased to be employed by Sharing Services Global Corporation (the “Company”) or any of its subsidiaries.
to replace Mark DiSiena who’s resignation from his position as Chief Financial Officer was effective November 15, 2024.
Departed
Michaela Griggs
Director
Guardion Health Sciences, Inc.
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
Effective as of November 14, 2024, Michaela Griggs and Don Gagliano resigned from the Board of the Company
Departed
Don Gagliano
Director
Guardion Health Sciences, Inc.
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
Effective as of November 14, 2024, Michaela Griggs and Don Gagliano resigned from the Board of the Company
Departed
Mark Castaneda
Director
Gold Flora Corp.
Effective
2024-11-30
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Mark Castaneda notified the Board of Directors (the “Board”) of Gold Flora Corporation (the “Company”) that he will resign as a member of the Board and its committees, effective as of November 30, 2024.
On November 14, 2024, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the "Company"), began a medical leave of absence.
Departed
Jeffrey S. Berkes
President and Chief Operating Officer
Federal Realty OP LP
Effective
2024-12-31
Filed
November 15, 2024, 6:59 PM ET
On November 15, 2024, Federal Realty Investment Trust (the “Company”) reported that Jeffrey S. Berkes, the Company’s President and Chief Operating Officer, will depart from the Company effective as of December 31, 2024.
On November 14, 2024, Thomas M. White, the Chairman of the Board of Directors (the "Board") of Sterling Infrastructure, Inc. (the "Company"), notified the Company of his intention to retire from the Board effective December 31, 2024.
On November 12, 2024, Matthew D’Ambrosio resigned as a member of the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”), the Compensation Committee of the Board, and the Quality, Compliance, and Governance Committee of the Board, effective as of November 12, 2024.
Departed
Wayne E. Hardesty
Director
PISMO COAST VILLAGE INC
Effective
2024-09-17
Successor
Kim Dougherty
Filed
November 15, 2024, 6:59 PM ET
the resignation of Wayne E. Hardesty at the Pismo Coast Village Board meeting held on September 17, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.